These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33493091)

  • 1. Spontaneous Lung Fibrosis Resolution Reveals Novel Antifibrotic Regulators.
    Tan Q; Link PA; Meridew JA; Pham TX; Caporarello N; Ligresti G; Tschumperlin DJ
    Am J Respir Cell Mol Biol; 2021 Apr; 64(4):453-464. PubMed ID: 33493091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldehyde Dehydrogenase 2 Deficiency Aggravates Lung Fibrosis through Mitochondrial Dysfunction and Aging in Fibroblasts.
    Wei Y; Gao S; Li C; Huang X; Xie B; Geng J; Dai H; Wang C
    Am J Pathol; 2024 Aug; 194(8):1458-1477. PubMed ID: 38777148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis.
    Redente EF; Chakraborty S; Sajuthi S; Black BP; Edelman BL; Seibold MA; Riches DW
    JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted regulation of fibroblast state by CRISPR-mediated CEBPA expression.
    Liu W; Meridew JA; Aravamudhan A; Ligresti G; Tschumperlin DJ; Tan Q
    Respir Res; 2019 Dec; 20(1):281. PubMed ID: 31829168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
    Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.
    Xie Y; Jiang H; Zhang Q; Mehrotra S; Abel PW; Toews ML; Wolff DW; Rennard S; Panettieri RA; Casale TB; Tu Y
    Respir Res; 2016 Aug; 17(1):103. PubMed ID: 27549302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung fibroblasts express a miR-19a-19b-20a sub-cluster to suppress TGF-β-associated fibroblast activation in murine pulmonary fibrosis.
    Souma K; Shichino S; Hashimoto S; Ueha S; Tsukui T; Nakajima T; Suzuki HI; Shand FHW; Inagaki Y; Nagase T; Matsushima K
    Sci Rep; 2018 Nov; 8(1):16642. PubMed ID: 30413725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state.
    Caporarello N; Meridew JA; Jones DL; Tan Q; Haak AJ; Choi KM; Manlove LJ; Prakash YS; Tschumperlin DJ; Ligresti G
    Thorax; 2019 Aug; 74(8):749-760. PubMed ID: 31182654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBX5/G9a/H3K9me-mediated gene repression is essential to fibroblast activation during lung fibrosis.
    Ligresti G; Caporarello N; Meridew JA; Jones DL; Tan Q; Choi KM; Haak AJ; Aravamudhan A; Roden AC; Prakash YS; Lomberk G; Urrutia RA; Tschumperlin DJ
    JCI Insight; 2019 May; 5(12):. PubMed ID: 31095524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual inhibition of α
    Decaris ML; Schaub JR; Chen C; Cha J; Lee GG; Rexhepaj M; Ho SS; Rao V; Marlow MM; Kotak P; Budi EH; Hooi L; Wu J; Fridlib M; Martin SP; Huang S; Chen M; Muñoz M; Hom TF; Wolters PJ; Desai TJ; Rock F; Leftheris K; Morgans DJ; Lepist EI; Andre P; Lefebvre EA; Turner SM
    Respir Res; 2021 Oct; 22(1):265. PubMed ID: 34666752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA FENDRR Exhibits Antifibrotic Activity in Pulmonary Fibrosis.
    Huang C; Liang Y; Zeng X; Yang X; Xu D; Gou X; Sathiaseelan R; Senavirathna LK; Wang P; Liu L
    Am J Respir Cell Mol Biol; 2020 Apr; 62(4):440-453. PubMed ID: 31697569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel profibrotic mechanism mediated by TGFβ-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells.
    Luo Y; Xu W; Chen H; Warburton D; Dong R; Qian B; Selman M; Gauldie J; Kolb M; Shi W
    J Pathol; 2015 Jul; 236(3):384-94. PubMed ID: 25779936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase and telomere length in pulmonary fibrosis.
    Liu T; Ullenbruch M; Young Choi Y; Yu H; Ding L; Xaubet A; Pereda J; Feghali-Bostwick CA; Bitterman PB; Henke CA; Pardo A; Selman M; Phan SH
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):260-8. PubMed ID: 23526226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the Activated Fibroblast Population in Lung Fibrosis Using Single-Cell Sequencing.
    Peyser R; MacDonnell S; Gao Y; Cheng L; Kim Y; Kaplan T; Ruan Q; Wei Y; Ni M; Adler C; Zhang W; Devalaraja-Narashimha K; Grindley J; Halasz G; Morton L
    Am J Respir Cell Mol Biol; 2019 Jul; 61(1):74-85. PubMed ID: 30848683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation.
    Aravamudhan A; Haak AJ; Choi KM; Meridew JA; Caporarello N; Jones DL; Tan Q; Ligresti G; Tschumperlin DJ
    Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L852-L863. PubMed ID: 32159970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of H4K16Ac levels reduces pro-fibrotic gene expression and mitigates lung fibrosis in aged mice.
    Zhang X; Liu H; Zhou JQ; Krick S; Barnes JW; Thannickal VJ; Sanders YY
    Theranostics; 2022; 12(2):530-541. PubMed ID: 34976199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SH2 Domain-Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis.
    Tzouvelekis A; Yu G; Lino Cardenas CL; Herazo-Maya JD; Wang R; Woolard T; Zhang Y; Sakamoto K; Lee H; Yi JS; DeIuliis G; Xylourgidis N; Ahangari F; Lee PJ; Aidinis V; Herzog EL; Homer R; Bennett AM; Kaminski N
    Am J Respir Crit Care Med; 2017 Feb; 195(4):500-514. PubMed ID: 27736153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial cell-derived cytokines CST3 and GDF15 as potential therapeutics for pulmonary fibrosis.
    Kim YI; Shin HW; Chun YS; Cho CH; Koh J; Chung DH; Park JW
    Cell Death Dis; 2018 May; 9(5):506. PubMed ID: 29724997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.